SIO2 MEDICAL PRODUCTS INC

Auburn, AL · CIK 0001743644 · Medtech · Acquired

Hybrid glass-plastic primary containers for injectable drugs and autoinjectors that are shatterproof and durable

sio2ms.com →
Grants
$1.0M
2 awards
Sector median: 1
Raised
$48M
1 Form D · Oct 2019
84 months since last filing
Contracts
$1.1M
1 award · Defense
#309 of 4531 in medtech
Patents
40
17 granted · 23 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$48,000,000
Federal grantDepartment of Defense · Phase I · Austere environment, durable, safe, glass equivalent auto injector container technology$160,501
Federal contract· 1 of 2 same dayDepartment of Defense · SBIR Phase II Year One$1,092,074
Federal grant· 2 of 2 same dayDepartment of Defense · Phase II · Austere environment, durable, safe, glass equivalent auto injector container technology$857,168
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
306TELA Bio, Inc.$1.1M$105M
307MODULAR MATTER, INC.$1.1M—
308Fenix Research Corporation$1.1M—
309SIO2 MEDICAL PRODUCTS INC$1.1M$48M
310AVENTUSOFT L.L.C$1.1M—
311SIM-VIVO LLC$1.1M—
312MICROPROBES FOR LIFE SCIENCE INC$1.0M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Robert AbramsDirector · Executive Officer
  • John BelfanceDirector
  • Helmut JeggleDirector
  • Jared MorrisDirector
  • Jean-Marie PainvinDirector
  • Robert PangbornDirector
  • Anthony RosenbergDirector
  • Melissa SimonDirector
  • John SteinDirector
  • Thomas StrungmannDirector

Patents

USPTO · 17 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.